USDA Rural Health and Safety Education Competitive Grants Program (Land Grant only)

Sponsor Deadline: 

Apr 29, 2021


USDA National Institute of Food and Agriculture NIFA

UI Contact: 

USDA Rural Health and Safety Education Competitive Grants Program (Land Grant eligible only)
NIFA url
FY 2021 Deadline  April 29, 2021

Applications may be submitted by 1862 and 1890 Land Grant colleges and universities and 1994 Land Grant Institutions. The University of Iowa is not eligible as an applicant, however award recipients may subcontract to organizations not eligible to apply provided such organizations are necessary for the conduct of the project.
Limited to one application per institution. Duplicate or multiple submissions are not allowed. NIFA will disqualify both/all applications if an applicant institution submits duplicate or multiple submissions

In FY 2020 and FY 2021, NIFA is soliciting applications for RHSE in the area of Individual and Family Health Education.The RHSE program proposals in the individual and family health education area are expected to be health education projects that provide individuals and families living in rural areas with:
•Information as to the value of good health at any age;
•Information to increase individual or families’ motivation to take more responsibility for their own health, including in the context of the COVID-19 pandemic; •Information about and access to health promotion activities;
•Information to support the utilization of telehealth, telemedicine, and distance learning strategies for opioid education and training in minority rural communities.
•Training for volunteers and health services providers concerning health promotion and health care services for individuals and families in cooperation with state, local and community partners.
Proposals submitted to the RHSE program in FY 2020 and FY 2021 may focus on the prevention and/or reduction of opioid misuse and abuse per Congressional guidance for this program. Proposals may also focus on helping prevent spread of SARS-CoV-2 and in mitigating infection and transmission of SARS-CoV-2.